HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Legal Issues Dietary Supplements FDA

Second Atlanta-Area Business Faces Criminal Charges Linked To Steroid-Spiked Supplements

CCB Nutrition Owner Pleads Guilty; Charges Pending Against Hi-Tech CEO Wheat

  • News

Executive Summary

CCB Nutrition owner pleads guilty in federal court to selling an unapproved new drug with the intent to defraud and mislead the FDA and consumers. Hi-Tech Pharmaceuticals CEO still faces criminal charges after Supreme Court refused his appeal after trial and appellate court rejected motion to dismiss an indictment alleging he distributed steroid-spiked supplements and falsified compliance documents.

Table

View full table

Topics

Tags:
Legal Issues Dietary Supplements FDA
Latest Headlines

Haleon Capitalizes On Global Rebound Of Dietary Supplement Sales

Chanelle McCoy, Cannaray First To Pass UK FSA’s CBD Safety Assessment

OTC Marketing Awards 2024 Now Open For Entries

Hot Or Bot? ‘Miss AI’ Pageant Will Judge Human Influencers’ New Competition

See All
UsernamePublicRestriction

Register

RS151488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By